These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 5088171)
1. [Neurovirulence of the French neurotropic strain of the yellow fever virus: its study by the thermal sensitivity of viral development and analysis of viral populations obtained by the plaque method]. Brès P; Robin Y; Héry G Ann Inst Pasteur (Paris); 1971 May; 120(5):671-82. PubMed ID: 5088171 [No Abstract] [Full Text] [Related]
2. [Culture of the French neurotropic strain of yellow fever virus on the continuous pig kidney cells, PS-2]. Brès P; Robin Y; Héry G Ann Inst Pasteur (Paris); 1971 Feb; 120(2):243-55. PubMed ID: 5102651 [No Abstract] [Full Text] [Related]
3. [Analysis of virus populations obtained by the plaque method with the French strain of viscerotropic yellow fever virus]. Martin M Ann Inst Pasteur (Paris); 1969 Mar; 116(3):391-403. PubMed ID: 5771874 [No Abstract] [Full Text] [Related]
4. The opposite temperature-sensitivity character (ts) in two attenuated flaviviruses, used for human immunization: 17D yellow fever and E5"14" (Langat) viruses. A reappraisal of thoughts. Mayer V Acta Virol; 1976 Oct; 20(5):361-5. PubMed ID: 11663 [TBL] [Abstract][Full Text] [Related]
5. [Culture of the French strain of viscerotropic yellow fever virus on pig kidney cells]. Martin M; Brès P Ann Inst Pasteur (Paris); 1969 Mar; 116(3):383-90. PubMed ID: 5771873 [No Abstract] [Full Text] [Related]
6. [Long-term infection of a cell culture from newborn mouse brain with the FNV strain of yellow fever virus (author's transl)]. Fleury H; Adam C; Heme G Ann Microbiol (Paris); 1977; 128B(4):541-5. PubMed ID: 565183 [TBL] [Abstract][Full Text] [Related]
7. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity. Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837 [TBL] [Abstract][Full Text] [Related]
8. [Cytopathogenic effect and production of yellow fever virus with the FNV strain in cell culture]. Brès P; Martin M; Robin Y Ann Inst Pasteur (Paris); 1966 Apr; 110(4):549-55. PubMed ID: 5908536 [No Abstract] [Full Text] [Related]
9. The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture. Holbrook MR; Li L; Suderman MT; Wang H; Barrett AD Virus Res; 2000 Aug; 69(1):31-9. PubMed ID: 10989183 [TBL] [Abstract][Full Text] [Related]
10. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294 [TBL] [Abstract][Full Text] [Related]
11. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116 [TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Muylaert IR; Chambers TJ; Galler R; Rice CM Virology; 1996 Aug; 222(1):159-68. PubMed ID: 8806496 [TBL] [Abstract][Full Text] [Related]
13. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus. Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387 [TBL] [Abstract][Full Text] [Related]
14. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154 [TBL] [Abstract][Full Text] [Related]
15. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it. Jennings AD; Whitby JE; Minor PD; Barrett AD Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909 [TBL] [Abstract][Full Text] [Related]
18. A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus. Maier CC; Delagrave S; Zhang ZX; Brown N; Monath TP; Pugachev KV; Guirakhoo F Virology; 2007 Jun; 362(2):468-74. PubMed ID: 17303204 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Engel AR; Vasconcelos PF; McArthur MA; Barrett AD Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518 [TBL] [Abstract][Full Text] [Related]
20. LOSS IN VIRULENCE OF YELLOW FEVER VIRUS SERIALLY PASSED IN HELA CELLS. HEARN HJ; SOPER WT; MILLER WS Proc Soc Exp Biol Med; 1965 Jun; 119():319-22. PubMed ID: 14328877 [No Abstract] [Full Text] [Related] [Next] [New Search]